BioCentury | May 16, 2020
Management Tracks

Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix

...May 31. The mitochondria-based therapeutics company is seeking a successor. Infectious and inflammatory diseases company CorMedix Inc....
...at Ovid Therapeutics Inc. (NASDAQ:OVID). Robin Sawka, BioCentury Staff Evox Therapeutics Ltd. BridgeBio Artax Biopharma Inc. Nucleix Ltd. IsoPlexis Corp. Centogene Immunicum AB CohBar Inc. CorMedix Inc....
BioCentury | Nov 9, 2019
Company News

Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

...Scott Hutton will succeed David Brunel as CEO on Jan. 1. Brunel will become chairman. CorMedix Inc....
BioCentury | Jul 18, 2015
Company News

Management tracks

...R&D. Richard was CMO at Oxyrane U.K. Ltd. (Manchester, U.K.). Cardiorenal and infectious disease company CorMedix Inc....
BioCentury | May 11, 2015
Analyst Picks & Changes

Analyst picks & changes

...& changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/8 cls CorMedix Inc....
BioCentury | Apr 6, 2015
Finance

Up, up and acquired

...gain by a stock that began the quarter with a share price above $1 was CorMedix Inc....
...NASDAQ:CLLS), Paris, France Celsus Therapeutics plc (NASDAQ:CLTX), London, U.K. Chiome Bioscience Inc. (Tokyo:4583), Tokyo, Japan CorMedix Inc....
BioCentury | Feb 9, 2015
Clinical News

Neutrolin regulatory update

...Review. FDA granted the product Fast Track designation last month. Neutrolin has CE Mark approval. CorMedix Inc....
BioCentury | Jan 19, 2015
Clinical News

Neutrolin regulatory update

...Germany approved a label expansion for Neutrolin catheter lock solution from CorMedix to include use in...
...hemodialysis patients using a central venous catheter for vascular access (see BioCentury, July 22, 2013). CorMedix Inc....
BioCentury | Jul 28, 2014
Company News

CorMedix management update

CorMedix Inc. (NYSE-M:CRMD), Summit, N.J. Business: Renal, Cardiovascular Hired: Harry O’Grady as CFO Transitioned: Antony Pfaffle to CSO from interim CSO WIR Staff Cardiovascular Renal...
BioCentury | Jul 28, 2014
Financial News

CorMedix financial update

...CorMedix Inc. (NYSE-M:CRMD), Summit, N.J. Business: Renal, Cardiovascular Date announced: 2014-07-24 Note: CorMedix said NYSE MKT...
BioCentury | Jun 2, 2014
Financial News

CorMedix financial update

...fiscal years ended Dec. 31, 2013. The company has until Dec. 19 to regain compliance. CorMedix Inc....
Items per page:
1 - 10 of 45
BioCentury | May 16, 2020
Management Tracks

Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix

...May 31. The mitochondria-based therapeutics company is seeking a successor. Infectious and inflammatory diseases company CorMedix Inc....
...at Ovid Therapeutics Inc. (NASDAQ:OVID). Robin Sawka, BioCentury Staff Evox Therapeutics Ltd. BridgeBio Artax Biopharma Inc. Nucleix Ltd. IsoPlexis Corp. Centogene Immunicum AB CohBar Inc. CorMedix Inc....
BioCentury | Nov 9, 2019
Company News

Management tracks: Teva, Ipsen, ADC, Assembly, Kaleido, Biodesix, CorMedix, Ideaya, Partner, Neurana, Odylia and T1D Exchange

...Scott Hutton will succeed David Brunel as CEO on Jan. 1. Brunel will become chairman. CorMedix Inc....
BioCentury | Jul 18, 2015
Company News

Management tracks

...R&D. Richard was CMO at Oxyrane U.K. Ltd. (Manchester, U.K.). Cardiorenal and infectious disease company CorMedix Inc....
BioCentury | May 11, 2015
Analyst Picks & Changes

Analyst picks & changes

...& changes Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/8 cls CorMedix Inc....
BioCentury | Apr 6, 2015
Finance

Up, up and acquired

...gain by a stock that began the quarter with a share price above $1 was CorMedix Inc....
...NASDAQ:CLLS), Paris, France Celsus Therapeutics plc (NASDAQ:CLTX), London, U.K. Chiome Bioscience Inc. (Tokyo:4583), Tokyo, Japan CorMedix Inc....
BioCentury | Feb 9, 2015
Clinical News

Neutrolin regulatory update

...Review. FDA granted the product Fast Track designation last month. Neutrolin has CE Mark approval. CorMedix Inc....
BioCentury | Jan 19, 2015
Clinical News

Neutrolin regulatory update

...Germany approved a label expansion for Neutrolin catheter lock solution from CorMedix to include use in...
...hemodialysis patients using a central venous catheter for vascular access (see BioCentury, July 22, 2013). CorMedix Inc....
BioCentury | Jul 28, 2014
Company News

CorMedix management update

CorMedix Inc. (NYSE-M:CRMD), Summit, N.J. Business: Renal, Cardiovascular Hired: Harry O’Grady as CFO Transitioned: Antony Pfaffle to CSO from interim CSO WIR Staff Cardiovascular Renal...
BioCentury | Jul 28, 2014
Financial News

CorMedix financial update

...CorMedix Inc. (NYSE-M:CRMD), Summit, N.J. Business: Renal, Cardiovascular Date announced: 2014-07-24 Note: CorMedix said NYSE MKT...
BioCentury | Jun 2, 2014
Financial News

CorMedix financial update

...fiscal years ended Dec. 31, 2013. The company has until Dec. 19 to regain compliance. CorMedix Inc....
Items per page:
1 - 10 of 45